A Study to Evaluate Retisert in the Treatment of Patients With the Wet Form of Age-Related Macular Degeneration

Status

UNKNOWN

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00032396

Enrollment

Unknown

Registered

2002-03-22

Start date

2001-11-30

Completion date

Unknown

Last updated

2006-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macular Degeneration

Keywords

AMD, ARMD, Age-Related Macular Degeneration, Subfoveal Choroidal Neovascularization, CNV

Brief summary

A study evaluating Retisert in patients with age-related macular degeneration

Interventions

DRUGRetisert Implant

Study design

Primary purpose

TREATMENT

Eligibility

Sex/Gender

ALL

Age

55 Years to No maximum

Healthy volunteers

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026